PEX1 and B-cell non-Hodgkin lymphoma: Additionally, variants of PEX1 (Log2OR = 5.13, FDR = 3.07 × 10−3) were enriched in B-cell non-Hodgkin’s lymphoma (Lymph-BNHL), FLG2 (Log2OR = 5.04, FDR = 3.68 × 10−3) in Kidney-RCC, DHCR7 (Log2OR = 4.81, FDR = 4.76 × 10−3) in Breast-AdenoCA and FAM111A (Log2OR = 4.68, FDR = 7.70 × 10−3) in medulloblastoma (CNS-Medullo) also showed significant enrichment.